TWTingqing Wu

Tingqing Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tingqing Wu has a total of 121 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Health-Related Quality of Life in Older Patients With Advanced Heart Failure From Before to 2 Years After Heart Transplantation or Long-Term Mechanical Circulatory Support: Findings From the SUSTAIN-IT Study

    by Kathleen L. Grady, John A. Spertus, Mary Amanda Dew, Tingqing Wu, Scott Silvestry, Maryl Johnson, Eileen Hsich, Brent Lampert, Michael Petty, Salpy V. Pamboukian, et al.

    BACKGROUND: Health-related quality of life (HRQOL) is a key consideration among older patients with heart failure considering advanced therapies. We evaluated change in HRQOL from before to 24 months after heart transplantation (HT) or long-term mechanical circulatory support (MCS) among older (60–80 years) patients and identified factors associated with HRQOL changes. METHODS: Data for this observational study were collected from 13 US sites via patient self-reported measures (EuroQol-5-dimension-3L visual analog scale score: 0=worst–100=best imaginable health state and dimension scores; Kansas City Cardiomyopathy Questionnaire-12 overall summary score/domain scores: 0–100, higher=better health status; other measures) and a 6-minute walk test. Analyses included multivariable linear mixed-effects models. RESULTS: Of 393 enrollees, 305 underwent surgery: HT with pretransplant MCS (HT MCS)=69, HT without pretransplant MCS (HT non-MCS)=92, and long-term MCS=144. Cohort average age=66.9±4.7 years, 78% male, 83% White, 78% married/partnered, and 71% with >high school education. HT non-MCS and long-term MCS groups experienced significant improvement in average visual analog scale scores within 6 months after surgery, sustained through 24 months of follow-up; the HT MCS group EuroQol-5-dimension-3L baseline visual analog scale score was higher than those of the other 2 groups and did not improve significantly through 24 months of follow-up. The average Kansas City Cardiomyopathy Questionnaire-12 overall summary score improved in all 3 groups (baseline–6 months, sustained through 24 months). Compared with HT non-MCS, the main effect of long-term MCS showed decrements of −11.2 (−17.3 to −5.1; P P =0.002) points in EuroQol-5-dimension-3L visual analog scale. CONCLUSIONS: HT MCS improvement in HRQOL varied by measure; HT non-MCS and long-term MCS improvement occurred through 24 months, regardless of measure. Domains of HRQOL improved after these surgeries, varying by surgical strategy and postoperative time period. Long-term MCS was associated with a decrease in HRQOL across time. These findings provide important information for patients considering treatment options.

  • Open Access

    American Heart Association Life's Essential 8 and Heart Failure in Black Individuals: An Analysis of the National Health and Nutrition Examination Survey

    by Kiersten A. Rasberry, Olisemeka Oputa, Kaleb P. Boyd, Tolulope A. Agunbiade, Toluwalase A. Awoyemi, Jing Gao, Rebecca S. Harap, Tingqing Wu, Kamari Ositelu, Oluseyi Princewill, et al.

    Background: Self‐reported Black individuals have a disproportionately high prevalence of heart failure (HF) compared with other racial groups. In an effort to empower patients and health providers to combat cardiovascular disease, the American Heart Association identified Life's Essential 8 as the 8 health behaviors crucial for heart health. In this study, we evaluate the association between components of Life's Essential 8 and HF outcomes among Black individuals. Methods: This cross‐sectional observational study analyzed 107 622 individuals captured in the NHANES (National Health and Nutrition Examination Survey) from 1999 to 2020 who were categorized by self‐reported race. To represent Life's Essential 8, variables of self‐reported sleep duration, physical activity, smoking status, and dietary habits were used. Additionally, self‐reported diagnoses of diabetes, hyperlipidemia, hypertension, and heart failure were included. Multivariable logistic regression models were constructed to estimate odds ratios (ORs) and 95% CIs for the associations between Life's Essential 8 components and HF among Black individuals. Results: Black individuals were diagnosed with HF at a younger age compared with White individuals (54 years vs 65 years, P P =0.02), hypertension (OR, 3.175 [95% CI, 2.14–4.69], P P =0.02), and diabetes (OR, 2.07 [95% CI, 1.60–2.67], P ≤0.0001) were associated with increased odds of HF. Physical activity was associated with lower odds (OR, 0.564 [95% CI, 0.38–0.836], P =0.004) of HF in Black individuals. Conclusions: Black individuals experienced HF at significantly younger ages, with traditional cardiometabolic factors (body mass index, hypertension, hyperlipidemia, diabetes) each independently being associated with HF risk. Physical activity appears protective, underscoring the importance of early, targeted prevention strategies.

  • Open Access

    Effect of Concomitant Tricuspid Valve Repair on Clinical and Echocardiographic Outcomes in Patients Undergoing Left Ventricular Assist Device Implantation

    by Olga N. Kislitsina, Sandeep N. Bharadwaj, Tingqing Wu, Rebecca Harap, Jane Kruse, Esther B. Vorovich, Jane E. Wilcox, Clyde W. Yancy, Patrick M. McCarthy, Duc T. Pham

    Objectives: The purpose of this study was to determine whether concomitant tricuspid valve repair (TVr) at the time of left ventricular assist device (LVAD) implantation improves outcomes in patients with ≥moderate tricuspid regurgitation (TR) and to evaluate the prognostic value of preoperative right ventricular (RV) strain. Methods: In a retrospective analysis of 100 LVAD recipients (44 TVr; 56 No-TVr), preoperative (preop) and postoperative (postop) clinical, echocardiographic, and hemodynamic variables, including pulmonary vascular resistance (PVR) and pulmonary artery pulsatility index (PAPI), were analyzed. RV free wall strain (RV-FWS) and RV fractional area change (RV-FAC) were measured by speckle tracking. Early right heart failure (RHF) was modeled with multivariable logistic regression, and 2-year mortality was assessed with Fine–Gray competing risk regression. Preoperative and three-month measurements were compared within each of the 100 patients. Results: Baseline invasive hemodynamics, RV-FWS, and RV-FAC were similar between the TVr and No-TVr groups. TVr at the time of LVAD implantation reduced postoperative TR grade, but it did not improve RV-FWS or RV-FAC at 3 months. The No-TVr patients were more often discharged home and had lower 30-day readmissions. PVR was comparable preoperatively and at 3 months postoperatively. In adjusted analyses, preop PVR, PAPI, and TVr were not independently associated with early RHF, whereas decreased preoperative RV-FWS and lower preop RV-FAC independently predicted higher 2-year mortality. Conclusions: In LVAD recipients with ≥moderate TR, concomitant TVr lowers postoperative TR severity but does not improve early RHF, RV strain-based remodeling, or 2-year mortality. Preoperative RV deformation metrics, rather than preoperative PVR or PAPI, independently predict survival following LVAD implantation with or without TVr.


  • Open Access

    Does race influence health-related quality of life outcomes in older patients who undergo advanced cardiac surgical therapies?

    by Jerian Dixon-Evans, Tingqing Wu, Adin-Cristian Andrei, Shondra Clay, Kathryn Mazurek, Kathleen L. Grady


  • Impact of Heart Transplant Allocation Change on Waitlist Mortality and Posttransplant Mortality in Patients With Left Ventricular Assist Devices

    by Anjan Tibrewala, Sarah Chuzi, Tingqing Wu, Abigail S. Baldridge, Rebecca Harap, Benjamin Bryner, Duc Thinh Pham, Jane E. Wilcox

    BACKGROUND: In October 2018, the US heart transplant (HT) allocation system was revised giving patients with left ventricular assist device (LVAD) intermediate priority status. Few studies have examined the impact of this policy change on outcomes among patients with LVAD. We sought to determine how the allocation change impacted waitlist and posttransplant mortality in patients with LVAD. METHODS: We retrospectively assessed the United Network for Organ Sharing registry for patients with LVAD who were listed for or underwent HT between October 2016 and October 2021. We evaluated waitlist mortality using competing risks analysis and a multivariable Fine-Gray model, and posttransplant mortality using Kaplan-Meier survival analysis and a multivariate proportional hazards model. RESULTS: We analyzed data from 3835 patients with LVAD listed for HT and 3486 patients with LVAD who underwent HT during the study period. Listing for HT preallocation change was significantly associated with an increased risk of waitlist mortality (Gray P =0.0058) compared with postallocation change. After adjustment for covariates, mortality differences by listing era were attenuated, but LVAD brand was significantly associated with waitlist mortality (HM3 versus HMII; hazard ratio, 0.38 [95% CI, 0.21–0.69]; P =0.002; HVAD versus HMII; hazard ratio, 0.79 [95% CI, 0.48–1.30]; P =0.36; overall P =0.004). In contrast, HT postallocation change was associated with increased posttransplant mortality (log-rank P =0.0172) compared with preallocation change. In a multivariable analysis, the association with posttransplant mortality between transplant eras was attenuated, but ischemic time (hazard ratio, 1.16 [95% CI, 1.07–1.26]; P P =0.02) were significantly associated with posttransplant mortality. CONCLUSIONS: Among patients with LVAD, lower waitlist mortality postallocation change was likely driven by improved LVAD technology. Higher posttransplant mortality following the allocation change was largely attributable to longer ischemic times and patient acuity.


  • Association of Patient Reported Outcomes With Caregiver Burden in Older Patients With Advanced Heart Failure: Insights From the SUSTAIN-IT Study

    by Dan D. Nguyen, John A. Spertus, Mary C. Benton, Merrill Thomas, Philip G. Jones, Adin-Cristian Andrei, Tingqing Wu, Abigail S. Baldridge, Kathleen L. Grady

    BACKGROUND: Caregivers of patients with advanced heart failure may experience burden in providing care, but whether changes in patient health status are associated with caregiver burden is unknown. METHODS: This observational study included older patients (60–80 years old) receiving advanced surgical heart failure therapies and their caregivers at 13 US sites. Patient health status was assessed using the 12-item Kansas City Cardiomyopathy Questionnaire (range, 0–100; higher scores are better). Caregiver burden was assessed using the Oberst Caregiving Burden Scale, which measures time on task (OCBS-time) and task difficulty (OCBS-difficulty; range, 1–5; lower scores are better). Measurements occurred before surgery and 12 months after in 3 advanced heart failure cohorts: patients receiving long-term left ventricular assist device support; heart transplantation with pretransplant left ventricular assist device support; and heart transplantation without pretransplant left ventricular assist device support. Multivariable linear regression was used to identify predictors of change in OCBS-time and OCBS-difficulty at 12 months. RESULTS: Of 162 caregivers, the mean age was 61.0±9.4 years, 139 (86%) were female, and 140 (86%) were the patient’s spouse. At 12 months, 99 (61.1%) caregivers experienced improved OCBS-time, and 61 (37.7%) experienced improved OCBS-difficulty (versus no change or worse OCBS). A 10-point higher baseline 12-item Kansas City Cardiomyopathy Questionnaire predicted lower 12-month OCBS-time (β=−0.09 [95% CI, −0.14 to −0.03]; P P P =0.002) and OCBS-difficulty (β=−0.09 [95% CI, −0.12 to −0.06]; P <0.001). CONCLUSIONS: Among survivors at 12 months, baseline and change in patient health status were associated with subsequent caregiver time on task and task difficulty in dyads receiving advanced heart failure surgical therapies, highlighting the potential for serial 12-item Kansas City Cardiomyopathy Questionnaire assessments to identify caregivers at risk of increased burden. REGISTRATION: URL: https://www.clinicaltrials.gov ; unique identifier: NCT02568930.


  • Race, substance use, and evaluation for heart transplantation: Insights from a large urban medical center

    by Sarah Chuzi, Elizabeth Cabrera, Onyedika Ilonze, Alyssa Vela, Lindsay Pifer, Tingqing Wu, Abigail S. Baldridge, Rebecca Harap, Quentin Youmans, Kambiz Ghafourian, et al.


  • A comparison of quality-adjusted life years in older adults after heart transplantation versus long-term mechanical support: Findings from the SUSTAIN-IT study

    by Kathleen L. Grady, Mary Amanda Dew, Francis D. Pagani, John A. Spertus, Eileen Hsich, Melana Yuzefpolskaya, Brent Lampert, James K. Kirklin, Michael Petty, Andrew Kao, et al.


  • Change in Caregiver Health-Related Quality of Life From Before to Early After Surgery: SUSTAIN-IT Study

    by Sarah Chuzi, Jane E. Wilcox, Andrew Kao, John A. Spertus, Eileen Hsich, Mary Amanda Dew, Clyde W. Yancy, Duc T. Pham, Justin Hartupee, Michael Petty, et al.

    BACKGROUND: Information about health-related quality of life (HRQOL) among caregivers of older patients with heart failure who receive heart transplantation (HT) and mechanical circulatory support (MCS) is sparse. We describe differences and factors associated with change in HRQOL before and early post-surgery among caregivers of older heart failure patients who underwent 3 surgical therapies: HT with pretransplant MCS (HT MCS), HT without pretransplant MCS (HT non-MCS), and long-term MCS. METHODS: Caregivers of older patients (60–80 years) from 13 US sites completed the EQ-5D-3 L visual analog scale (0 [worst]–100 [best] imaginable health state) and dimensions before and 3 and 6 months post-surgery. Analyses included linear regression, t tests, and nonparametric tests. RESULTS: Among 227 caregivers (HT MCS=54, HT non-MCS=76, long-term MCS=97; median age 62.7 years, 30% male, 84% White, 83% spouse/partner), EQ-5D visual analog scale scores were high before (84.8±14.1) and at 3 (84.7±13.0) and 6 (83.9±14.7) months post-surgery, without significant differences among groups or changes over time. Patient pulmonary hypertension presurgery (β=−13.72 [95% CI, −21.07 to −6.36]; P P =0.035) were associated with the largest decrements in caregiver HRQOL; patient marital/partner status (β=6.21 [95% CI, 1.34–11.08]; P =0.013) and presurgery coronary disease (β=8.98 [95% CI, 4.07–13.89]; P <0.001) were associated with the largest improvements. CONCLUSIONS: Caregivers of older patients undergoing heart failure surgeries reported overall high HRQOL before and early post-surgery. Understanding factors associated with caregiver HRQOL may inform decision-making and support needs. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02568930.


  • Caregiver burden before heart transplantation and long-term mechanical circulatory support: Findings from the sustaining quality of life of the aged: Transplant or mechanical support (SUSTAIN-IT) study

    by Ike S. Okwuosa, Allen Anderson, Michael Petty, Tingqing Wu, Adin-Cristian Andrei, Andrew Kao, John A. Spertus, Duc T. Pham, Clyde W. Yancy, Mary Amanda Dew, et al.